Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.
Elevation of mean pulmonary arterial pressure (MPAP) is associated with poor prognosis in patients with idiopathic pulmonary fibrosis (IPF), yet the progression of MPAP in patients with IPF has not been sufficiently elucidated. We evaluated serial changes in MPAP and its determinants in patients with IPF with mild to moderate restriction.
We retrospectively reviewed patients with IPF who underwent initial evaluations including right heart catheterization (RHC) in our institute from May 2007 to December 2013 with follow-up RHC at least 1 year later. Patients with forced vital capacity (FVC) < 50% predicted or those with pulmonary artery wedge pressure >15 mm Hg were excluded.
A total of 95 patients were included. Median follow-up time of second RHC was 1.8 years. MPAP increased significantly at follow-up (from 16.8 to 20.2 mm Hg; P < 0.001), and annual change in MPAP (ΔMPAP) was 1.8 mm Hg/year. In multiple regression analysis, the lowest oxygen saturation (SpO ) at 6-min walk test (6MWT) was an independent predictor of ΔMPAP. When adjusted for age, sex, baseline MPAP and FVC % predicted, ΔMPAP was a significant predictor of mortality (hazard ratio: 1.21; P = 0.001).
ΔMPAP was significantly associated with desaturation in the 6MWT, and with increased mortality in patients with IPF with mild to moderate restriction.
平均肺动脉压(MPAP)升高与特发性肺纤维化(IPF)患者预后不良相关,但 IPF 患者 MPAP 的进展尚未得到充分阐明。我们评估了伴有轻度至中度限制的 IPF 患者 MPAP 及其决定因素的连续变化。
我们回顾性分析了 2007 年 5 月至 2013 年 12 月在我院接受初始评估(包括右心导管检查[RHC])并在至少 1 年后进行后续 RHC 的 IPF 患者。排除了用力肺活量(FVC)<50%预计值或肺动脉楔压>15mmHg 的患者。
共纳入 95 例患者。第二次 RHC 的中位随访时间为 1.8 年。MPAP 在随访时显著升高(从 16.8 至 20.2mmHg;P<0.001),MPAP 的年变化量(ΔMPAP)为 1.8mmHg/年。多元回归分析显示,6 分钟步行试验(6MWT)时的最低血氧饱和度(SpO )是ΔMPAP 的独立预测因子。在校正年龄、性别、基线 MPAP 和 FVC%预计值后,ΔMPAP 是死亡率的显著预测因子(危险比:1.21;P=0.001)。
ΔMPAP 与 6MWT 中的低氧血症显著相关,与伴有轻度至中度限制的 IPF 患者的死亡率增加相关。